Nexgel Inc (NXGL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nexgel Inc (NXGL) has a cash flow conversion efficiency ratio of -0.112x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-504.00K) by net assets ($4.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Nexgel Inc worth for the company's overall valuation and market capitalisation.
Nexgel Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Nexgel Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nexgel Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexgel Inc ranked by their cash flow conversion efficiency. Explore NXGL cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Easson Holdings Ltd
PA:MLEAS
|
N/A |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
-0.010x |
|
Vp plc
LSE:VP
|
0.245x |
|
Tristel
LSE:TSTL
|
0.161x |
|
MOBA Network publ AB
ST:MOBA
|
0.084x |
|
Jost AG
MU:JOX
|
N/A |
|
Sodas Sodyum Sanayi AS
IS:SODSN
|
0.362x |
|
Galeo Concept SA
PA:MLGAL
|
N/A |
Annual Cash Flow Conversion Efficiency for Nexgel Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Nexgel Inc from 2016 to 2025. View latest Nexgel Inc stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.89 Million | $-1.31 Million | -0.268x | +57.86% |
| 2024-12-31 | $6.08 Million | $-3.87 Million | -0.636x | -1.54% |
| 2023-12-31 | $5.17 Million | $-3.24 Million | -0.626x | -59.89% |
| 2022-12-31 | $7.64 Million | $-2.99 Million | -0.392x | -71.98% |
| 2021-12-31 | $12.09 Million | $-2.75 Million | -0.228x | +99.10% |
| 2020-12-31 | $71.00K | $-1.80 Million | -25.366x | -431.38% |
| 2019-12-31 | $380.00K | $-1.81 Million | -4.774x | +13.12% |
| 2018-12-31 | $281.00K | $-1.54 Million | -5.495x | -341.98% |
| 2017-12-31 | $625.00K | $-777.00K | -1.243x | +25.05% |
| 2016-12-31 | $794.00K | $-1.32 Million | -1.659x | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more